What is Agios Pharmaceuticals's work in process?

Agios Pharmaceuticals (AGIO) reported work in process of $31.08M in Q1 2026.

How has Agios Pharmaceuticals's work in process changed year-over-year?

Agios Pharmaceuticals's work in process increased by 21.9% year-over-year, from $25.5M to $31.08M.

What does work in process mean?

Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.

Agios Pharmaceuticals AGIO Work in process

Work in process at other companies

PrecigenPGEN

$13.09M—

BioCryst PharmaceuticalsBCRX

$20.54M+17.9%

PfizerPFE

——

Vertex PharmaceuticalsVRTX

——

IncyteINCY

——

BioMarin PharmaceuticalsBMRN

——

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's work in process?: Agios Pharmaceuticals (AGIO) reported work in process of $31.08M in Q1 2026.
How has Agios Pharmaceuticals's work in process changed year-over-year?: Agios Pharmaceuticals's work in process increased by 21.9% year-over-year, from $25.5M to $31.08M.
What does work in process mean?: Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.